Assessing real-world vaccine effectiveness against severe forms of SARS-CoV-2 infection: An observational study from routine surveillance data in Switzerland

Assessing real-world vaccine effectiveness against severe forms of SARS-CoV-2 infection: An observational study from routine surveillance data in Switzerland

BACKGROUND: In Switzerland, SARS-CoV-2 vaccination campaigns started in early 2021. Vaccine coverage reached 65% of the population in December 2021, mostly with mRNA vaccines from Moderna and Pfizer-BioNtech. Simultaneously, the proportion of vaccinated among COVID-19-related hospitalisations and de...

Full description

Bibliographic Details
Main Authors: Althaus, C.L (Author), Anderegg, N. (Author), Colin, S. (Author), Hauser, A. (Author), Laube, A. (Author), Mäusezahl, M. (Author), Riou, J. (Author), Wagner, M. (Author), Zaffora, B. (Author)
Format: Article
Language:English
Published: EMH Schweizerischer Arzteverlag AG 2022
Subjects:
aged
Aged
Child, Preschool
COVID-19
COVID-19 Vaccines
epidemiology
human
Humans
preschool child
prevention and control
SARS-CoV-2
Switzerland
vaccine
Vaccine Efficacy
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items